RIO1.DERIO1.DEXETRA
Loading
Cash Flow Under PressureContracting
Percentile Rank21
3Y CAGR-19.4%
5Y CAGR-12.7%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
-19.4%/yr
vs +10.1%/yr prior
5Y CAGR
-12.7%/yr
Recent deceleration
Acceleration
-29.5pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.92B | -17.7% |
| 2024 | $5.98B | -26.0% |
| 2023 | $8.07B | -14.0% |
| 2022 | $9.38B | -47.8% |
| 2021 | $17.96B | +85.4% |
| 2020 | $9.69B | +2.8% |
| 2019 | $9.42B | +47.5% |
| 2018 | $6.39B | -32.0% |
| 2017 | $9.40B | +72.4% |
| 2016 | $5.45B | - |